Capsaicin (Synonyms: (E)-Capsaicin)

Name: Capsaicin
Brand: MedChemExpress
SKU: HY-10448
Rating: 5.0 (43 reviews)

Cat. No.: HY-10448 Purity: 99.85%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain-relieving, antioxidant, anti-inflammatory, anti-cancer and certain neurotoxic effects.

For research use only. We do not sell to patients.

Capsaicin Chemical Structure

CAS No. : 404-86-4

Size	Price	Stock	Quantity

Free Sample (0.1 - 0.5 mg)		Apply Now
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 99	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 99	In-stock	Estimated Time of Arrival: December 31
Solid
50 mg	USD 90	In-stock	Estimated Time of Arrival: December 31
100 mg	USD 150	In-stock	Estimated Time of Arrival: December 31
200 mg		Get quote
500 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 43 publication(s) in Google Scholar

Other Forms of Capsaicin:

(Z)-Capsaicin In-stock
Capsaicin (Purity 65%) Get quote
(E/Z)-Capsaicin-d₃ Get quote
Capsaicin-d₃ Get quote
Capsaicin-d₇ Get quote
Capsaicin (Standard) Get quote

40 Publications Citing Use of MCE Capsaicin

Cell Viability Assay

: Capsaicin purchased from MedChemExpress. Usage Cited in: Theranostics. 2020 Jun 24;10(17):7906-7920. [Abstract]; CNE2 and SUNE1 cell growth is inhibited by Capsaicin in a dose-dependent manner.

: Capsaicin purchased from MedChemExpress. Usage Cited in: Theranostics. 2020 Jun 24;10(17):7906-7920. [Abstract]; The expression of cell cycle-associated molecules is altered by Capsaicin treatment in both cell lines.The cell-cycle inhibitor p27Kip1 is upregulated after Capsaicin treatment while the G1-S phase transition marker cyclin D1 is downregulated. p38 phosphorylation levels are also decreased following capsaicin treatment.

: Capsaicin purchased from MedChemExpress. Usage Cited in: Clin Exp Pharmacol Physiol. 2017 Jul;44(7):803-814. [Abstract]; Western blot analysis showing that the CAP (0.5 mg/kg) injection inhibits the increase of p65 expression and phosphorylation at 24 h after I/R injury.

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All TRP Channel Isoform Specific Products:

View All Isoforms

TRPC TRPM TRPV TRPA TRPML

Biological Activity
Purity & Documentation
References
Customer Review

Description

Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain-relieving, antioxidant, anti-inflammatory, anti-cancer and certain neurotoxic effects^[1]^[2].

IC₅₀ & Target

EC50: 290 nM (hTRPV1, in HEK293 cell)^[1]

Cellular Effect

Cell Line	Type	Value	Description	References
A2058	IC₅₀	> 100 μM Compound: Capsaicin	Cytotoxicity against human A2058 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human A2058 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay	[PMID: 31104785]
B16-F10	IC₅₀	> 100 μM Compound: Capsaicin	Cytotoxicity against mouse B16F10 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against mouse B16F10 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay	[PMID: 31104785]
BGC-823	IC₅₀	4.659 μM Compound: 1	Antiproliferative activity against human BGC-823 cells assessed as reduction in cell viability incubated for 5 days by MTS assay Antiproliferative activity against human BGC-823 cells assessed as reduction in cell viability incubated for 5 days by MTS assay	[PMID: 33581557]
CHO	EC₅₀	25.9 nM Compound: 1; CAP	Agonist activity at human TRPV1 expressed in CHO cells assessed as increase in 45Ca2+ uptake incubated for 5 mins by liquid scintillation counting method Agonist activity at human TRPV1 expressed in CHO cells assessed as increase in 45Ca2+ uptake incubated for 5 mins by liquid scintillation counting method	[PMID: 31702924]
CHO	EC₅₀	44.8 nM Compound: 1; CAP	Agonist activity at rat TRPV1 expressed in CHO cells assessed as increase in 45Ca2+ uptake incubated for 5 mins by liquid scintillation counting method Agonist activity at rat TRPV1 expressed in CHO cells assessed as increase in 45Ca2+ uptake incubated for 5 mins by liquid scintillation counting method	[PMID: 31702924]
CHO	EC₅₀	44.8 nM Compound: Capsaicin	In vitro [Ca2+] influx relative to capsaicin by Rat Vanilloid receptor (VR1) expressing CHO cells In vitro [Ca2+] influx relative to capsaicin by Rat Vanilloid receptor (VR1) expressing CHO cells	[PMID: 12825950]
HBMEC-2	EC₅₀	16.37 μM Compound: Capsaicin	Neuroprotective activity against H2O2-induced cell damage in human HBMEC2 cells assessed as increase in cell viability preincubated for 24 hrs followed by H2O2 addition and measured after 4 hrs by MTT assay Neuroprotective activity against H2O2-induced cell damage in human HBMEC2 cells assessed as increase in cell viability preincubated for 24 hrs followed by H2O2 addition and measured after 4 hrs by MTT assay	[PMID: 31541868]
HCT-116	IC₅₀	40.16 μM Compound: Capsaicin	Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition measured after 72 hrs by crystal violet staining based assay Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition measured after 72 hrs by crystal violet staining based assay	[PMID: 34795858]
HEK293	EC₅₀	0.0039 μM Compound: Capsaicin	Agonist activity at human TRPV1 ion channel expressed in HEK293 cells assessed as calcium influx by fluo-4-Am-based fluorimetry Agonist activity at human TRPV1 ion channel expressed in HEK293 cells assessed as calcium influx by fluo-4-Am-based fluorimetry	[PMID: 22257892]
HEK293	EC₅₀	0.0053 μM Compound: 1a	Agonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as Ca2+ influx by Fluo-4 dye based assay Agonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as Ca2+ influx by Fluo-4 dye based assay	[PMID: 25666822]
HEK293	IC₅₀	0.008 μM Compound: 1a	Antagonist activity against human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsaicin-induced Ca2+ influx pre-treated 5 mins before capsaicin addition by Fluo-4 dye based assay Antagonist activity against human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsaicin-induced Ca2+ influx pre-treated 5 mins before capsaicin addition by Fluo-4 dye based assay	[PMID: 25666822]
HeLa	IC₅₀	> 50 μM Compound: CAP	Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay	[PMID: 29685681]
K562	IC₅₀	49.41 μM Compound: CAP	Antiproliferative activity against human K562 cells after 48 hrs by MTT assay Antiproliferative activity against human K562 cells after 48 hrs by MTT assay	[PMID: 29685681]
MCF7	IC₅₀	100 μM Compound: Capsaicin	Antiproliferative activity in human MCF7 cells assessed as cell growth inhibition by MTT assay Antiproliferative activity in human MCF7 cells assessed as cell growth inhibition by MTT assay	[PMID: 33508189]
MCF7	IC₅₀	49.97 μM Compound: CAP	Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay	[PMID: 29685681]
MDA-MB-231	IC₅₀	120 μM Compound: 24	Antiproliferative activity against human MDA-MB-231 cells incubated for 24 hrs by MTT assay Antiproliferative activity against human MDA-MB-231 cells incubated for 24 hrs by MTT assay	[PMID: 32686940]
NCI-H460	IC₅₀	30.66 μM Compound: Capsaicin	Antiproliferative activity against human NCI-H460 cells assessed as cell growth inhibition measured after 72 hrs by crystal violet staining based assay Antiproliferative activity against human NCI-H460 cells assessed as cell growth inhibition measured after 72 hrs by crystal violet staining based assay	[PMID: 34795858]
SH-SY5Y	EC₅₀	14.02 μM Compound: Capsaicin	Neuroprotective activity against H2O2-induced cell damage in human SH-SY5Y cells assessed as increase in cell viability preincubated for 24 hrs followed by H2O2 addition and measured after 4 hrs by MTT assay Neuroprotective activity against H2O2-induced cell damage in human SH-SY5Y cells assessed as increase in cell viability preincubated for 24 hrs followed by H2O2 addition and measured after 4 hrs by MTT assay	[PMID: 31541868]
SH-SY5Y	EC₅₀	2.32 μM Compound: Capsaicin	Agonist activity at rat TRPV1 expressed in human SH-SY5Y cells assessed as intracellular calcium accumulation by Fluo-4 NW dye based fluorescence assay Agonist activity at rat TRPV1 expressed in human SH-SY5Y cells assessed as intracellular calcium accumulation by Fluo-4 NW dye based fluorescence assay	[PMID: 30783490]
SK-MEL-25	IC₅₀	> 100 μM Compound: Capsaicin	Cytotoxicity against human SK-MEL-25 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human SK-MEL-25 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay	[PMID: 31104785]
SK-OV-3	IC₅₀	22.03 μM Compound: Capsaicin	Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition measured after 72 hrs by crystal violet staining based assay Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition measured after 72 hrs by crystal violet staining based assay	[PMID: 34795858]
T47D	IC₅₀	100 μM Compound: Capsaicin	Antiproliferative activity in human T47D cells assessed as cell growth inhibition by MTT assay Antiproliferative activity in human T47D cells assessed as cell growth inhibition by MTT assay	[PMID: 33508189]
U-87MG ATCC	IC₅₀	> 100 μM Compound: Capsaicin	Cytotoxicity against human U87 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay Cytotoxicity against human U87 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay	[PMID: 31104785]

In Vitro

Capsaicin (50-300 μM; 24-72 hours) shows an augmented decrease in cell growth in a dose- and time-dependent manner. The observed IC₅₀ value is around 150 μM^[2].
Capsaicin (50-300 μM; 24-72 hours) shows increase in cytosolic cytochrome c, activation of caspase 3 and PARP (p85) levels, and decreases anti-apoptotic Bcl-2 protein and increases pro-apoptotic Bad/Bax expression^[2].
Capsaicin increases the nuclear condensation, nuclear DNA fragmentation and sub-G1 DNA content^[2].
Capsaicin suppresses the cell cycle progression at the G1/S phase in FaDu cells by decreasing the expression of the regulators of cyclin B1 and D1, as well as cyclin-dependent protein kinases cdk-1, cdk-2 and cdk-4^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[2]

Cell Line:	Human pharyngeal squamous carcinoma cells (FaDu) cells
Concentration:	50 µM, 100 µM, 200 µM, and 300 µM
Incubation Time:	24 hours, 48 hours and 72 hours
Result:	Showed an augmented decrease in cell growth.

Apoptosis Analysis^[2]

Cell Line:	FaDu cells
Concentration:	50 µM, 100 µM and 200 µM
Incubation Time:	12 hours
Result:	Increased the activity of caspase 3 in a time-dependent manner.

Western Blot Analysis^[2]

Cell Line:	FaDu cells
Concentration:	200 µM
Incubation Time:	24 hours
Result:	The observed activation of caspase 3 and PARP (p85) levels.

In Vivo

Capsaicin suppresses the development of lung carcinoma by amending the protein expressions of apoptotic regulators p53, Bcl-2, Bax and caspase-3^[2].
Capsaicin (2 μg in 40 μL per mice, injected into the plantar surface of the left hind paw) induces pain-related behaviour in mice^[4].
Capsaicin (3-30 μg in 10 μL per rat, plantar injection) induces secondary mechanical hypersensitivity (SMH) (used clinically as a model to potentially predict neuropathic pain) in rats^[5].
Capsaicin (0-500 μg in 25 μL per rat, injected subcutaneously into the center of the right vibrissae pad) induces pain in the orofacial region or rats^[6].
In high dose, Capsaicin may should be adminstered under anesthesia condition^[7]^[8].
Capsaicin is more pungent than Dihydrocapsaicin (HY-N0361) ^[9].
Note: The spicy taste is choking, please take precautions.

Capsaicin ((E)-Capsaicin) LD50 under different circumstances:

Animal	Backgroud	Route	LD₅₀	References
Rat	adult	ip	10 mg/kg	^[10]
	female; 51-54 g	ip	10.40-13.20 mg/kg	^[11]
	female; 141 g	ip	9.50 mg/kg	^[11]
	male	po	161.2 mg/kg	^[12]
	female	po	148.1 mg/kg	^[12]
Mice	male; 25-35 g	iv	0.56 mg/kg	^[11]
	male	po	118.8 mg/kg	^[12]
	male	ip	7.56 mg/kg	^[10]
	female	po	97.4 mg/kg	^[12]
	female; 30 g	ip	6.50 mg/kg	^[11]
		ip	7.65 mg/kg	^[11]
		im	7.80 mg/kg	^[11]
		sc	9.00 mg/kg	^[11]
		po	60-75 mg/kg	^[11]
		po	190 mg/kg	^[11]
		pr	>218 mg/kg	^[11]
		dermal	>512 mg/kg	^[11]
		intratracheal	1.60 mg/kg	^[11]
Hamster	male; 65 g	ip	>120 mg/kg	^[11]
Guinea Pig	male; 405 g	ip	>1.10 mg/kg	^[11]
Rabbit	adult; 503 g	ip	>50 mg/kg	^[11]

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Swiss albino mice (20-25 g; 8-10 weeks old) induced by Benzo(a)pyrene^[3]
Dosage:	10 mg/kg
Administration:	Intraperitoneal administration; once in a week; for 14 weeks
Result:	Inhibited the development of mice lung carcinogenesis.

Clinical Trial

Molecular Weight

305.41

Formula

C₁₈H₂₇NO₃

CAS No.

404-86-4

Appearance

Solid

Color

White to off-white

SMILES

CC(C)/C=C/CCCCC(NCC1=CC=C(O)C(OC)=C1)=O

Structure Classification

Initial Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 1 year; -20°C, 6 months (protect from light)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (327.43 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Ethanol : 100 mg/mL (327.43 mM; Need ultrasonic)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	3.2743 mL	16.3714 mL	32.7429 mL
5 mM	0.6549 mL	3.2743 mL	6.5486 mL
10 mM	0.3274 mL	1.6371 mL	3.2743 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (protect from light). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% EtOH 90% Corn Oil
Solubility: ≥ 20 mg/mL (65.49 mM); Clear solution

This protocol yields a clear solution of ≥ 20 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (200.0 mg/mL) to 900 μL Corn oil, and mix evenly.
Protocol 2

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (8.19 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 3

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (8.19 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 4

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (8.19 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 1 year; -20°C, 6 months (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.85%

Select Batch:

Data Sheet (282 KB) SDS (476 KB)

COA (243 KB) HNMR (259 KB) LCMS (91 KB)

Handling Instructions (2659 KB)

References

[1]. McNamara FN, et al. Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br J Pharmacol. 2005 Mar;144(6):781-90. [Content Brief]

[2]. Shin YH, et al. The Effect of Capsaicin on Salivary Gland Dysfunction. Molecules. 2016 Jun 25;21(7). [Content Brief]

[3]. Anandakumar P, et al. Capsaicin provokes apoptosis and restricts benzo(a)pyrene induced lung tumorigenesis in Swiss albino mice. Int Immunopharmacol. 2013 Jun 6;17(2):254-259. [Content Brief]

[4]. Nah JJ, et al. Effect of ginsenosides, active components of ginseng, on capsaicin-induced pain-related behavior. Neuropharmacology. 2000 Aug 23;39(11):2180-4. [Content Brief]

[5]. Joshi SK, et al Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity. Neuroscience. 2006 Dec 1;143(2):587-96. [Content Brief]

[6]. Pelissier T, et al. The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine. Pain. 2002 Mar;96(1-2):81-7. [Content Brief]

[7]. Matsuda H, et al. Roles of capsaicin-sensitive sensory nerves, endogenous nitric oxide, sulfhydryls, and prostaglandins in gastroprotection by momordin Ic, an oleanolic acid oligoglycoside, on ethanol-induced gastric mucosal lesions in rats. Life Sci. 1999;65(2):PL27-32. [Content Brief]

[8]. Demirbilek S, et al. Small-dose capsaicin reduces systemic inflammatory responses in septic rats. Anesth Analg. 2004 Nov;99(5):1501-1507. [Content Brief]

[9]. Friedman JR, et al. Anticancer Activity of Natural and Synthetic Capsaicin Analogs. J Pharmacol Exp Ther. 2018 Mar;364(3):462-473. [Content Brief]

[10]. Glinsukon T, et al. Acute toxicity of capsaicin in several animal species[J]. Toxicon, 1980, 18(2): 215-220.

[11]. Kawada T, Iwai K. In vivo and in vitro metabolism of dihydrocapsaicin, a pungent principle of hot pepper [Capsicum annuum], in rats[J]. Agricultural and Biological Chemistry (Japan), 1985, 49(2).

[12]. Saito A, Yamamoto M. Acute oral toxicity of capsaicin in mice and rats[J]. The Journal of toxicological sciences, 1996, 21(3): 195-200.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO / Ethanol	1 mM	3.2743 mL	16.3714 mL	32.7429 mL	81.8572 mL
	5 mM	0.6549 mL	3.2743 mL	6.5486 mL	16.3714 mL
	10 mM	0.3274 mL	1.6371 mL	3.2743 mL	8.1857 mL
	15 mM	0.2183 mL	1.0914 mL	2.1829 mL	5.4571 mL
	20 mM	0.1637 mL	0.8186 mL	1.6371 mL	4.0929 mL
	25 mM	0.1310 mL	0.6549 mL	1.3097 mL	3.2743 mL
	30 mM	0.1091 mL	0.5457 mL	1.0914 mL	2.7286 mL
	40 mM	0.0819 mL	0.4093 mL	0.8186 mL	2.0464 mL
	50 mM	0.0655 mL	0.3274 mL	0.6549 mL	1.6371 mL
	60 mM	0.0546 mL	0.2729 mL	0.5457 mL	1.3643 mL
	80 mM	0.0409 mL	0.2046 mL	0.4093 mL	1.0232 mL
	100 mM	0.0327 mL	0.1637 mL	0.3274 mL	0.8186 mL

Capsaicin Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Capsaicin404-86-4(E)-CapsaicinTRP ChannelAutophagyApoptosisEndogenous MetaboliteTransient receptor potential channelsantioxidantanti-inflammatoryanti-cancerTRPV1cytochrome-ccaspase-3neuroprotectionInhibitorinhibitorinhibit

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社
Product Name			Salutation
Applicant Name *			Email Address *
Phone Number *			Organization Name *
Department *			Requested quantity *
Country or Region *
Remarks

Product Name			Lot #
Applicant Name *			Email Address *
Phone Number			Department *
Organization Name *			Country or Region *
Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

Capsaicin (Synonyms: (E)-Capsaicin)

Customer Review

Other Forms of Capsaicin:

Capsaicin Related Antibodies

40 Publications Citing Use of MCE Capsaicin

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All TRP Channel Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

Capsaicin Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Capsaicin Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report